Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

42 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Protection of cottontop tamarins against Epstein-Barr virus-induced malignant lymphoma by a prototype subunit vaccine.
Epstein MA, Morgan AJ, Finerty S, Randle BJ, Kirkwood JK. Epstein MA, et al. Among authors: finerty s. Nature. 1985 Nov 21-27;318(6043):287-9. doi: 10.1038/318287a0. Nature. 1985. PMID: 2999604
Latent Epstein-Barr virus infection in cottontop tamarins. A possible model for Epstein-Barr virus infection in humans.
Niedobitek G, Agathanggelou A, Finerty S, Tierney R, Watkins P, Jones EL, Morgan A, Young LS, Rooney N. Niedobitek G, et al. Among authors: finerty s. Am J Pathol. 1994 Oct;145(4):969-78. Am J Pathol. 1994. PMID: 7943186 Free PMC article.
Protective immunization against Epstein-Barr virus-induced disease in cottontop tamarins using the virus envelope glycoprotein gp340 produced from a bovine papillomavirus expression vector.
Finerty S, Tarlton J, Mackett M, Conway M, Arrand JR, Watkins PE, Morgan AJ. Finerty S, et al. J Gen Virol. 1992 Feb;73 ( Pt 2):449-53. doi: 10.1099/0022-1317-73-2-449. J Gen Virol. 1992. PMID: 1311367
Immunization of cottontop tamarins and rabbits with a candidate vaccine against the Epstein-Barr virus based on the major viral envelope glycoprotein gp340 and alum.
Finerty S, Mackett M, Arrand JR, Watkins PE, Tarlton J, Morgan AJ. Finerty S, et al. Vaccine. 1994 Oct;12(13):1180-4. doi: 10.1016/0264-410x(94)90240-2. Vaccine. 1994. PMID: 7839721
Replication-defective recombinant adenovirus expressing the Epstein-Barr virus (EBV) envelope glycoprotein gp340/220 induces protective immunity against EBV-induced lymphomas in the cottontop tamarin.
Ragot T, Finerty S, Watkins PE, Perricaudet M, Morgan AJ. Ragot T, et al. Among authors: finerty s. J Gen Virol. 1993 Mar;74 ( Pt 3):501-7. doi: 10.1099/0022-1317-74-3-501. J Gen Virol. 1993. PMID: 8383183
Not all potently neutralizing, vaccine-induced antibodies to Epstein-Barr virus ensure protection of susceptible experimental animals.
Epstein MA, Randle BJ, Finerty S, Kirkwood JK. Epstein MA, et al. Among authors: finerty s. Clin Exp Immunol. 1986 Mar;63(3):485-90. Clin Exp Immunol. 1986. PMID: 3011324 Free PMC article.
Demonstration in vitro of cell mediated immunity to Epstein-Barr virus in cotton-top tamarins.
Finerty S, Scullion FT, Morgan AJ. Finerty S, et al. Clin Exp Immunol. 1988 Aug;73(2):181-5. Clin Exp Immunol. 1988. PMID: 2846217 Free PMC article.
Prevention of Epstein-Barr (EB) virus-induced lymphoma in cottontop tamarins by vaccination with the EB virus envelope glycoprotein gp340 incorporated into immune-stimulating complexes.
Morgan AJ, Finerty S, Lovgren K, Scullion FT, Morein B. Morgan AJ, et al. Among authors: finerty s. J Gen Virol. 1988 Aug;69 ( Pt 8):2093-6. doi: 10.1099/0022-1317-69-8-2093. J Gen Virol. 1988. PMID: 2841417
Recombinant vaccinia virus expressing Epstein-Barr virus glycoprotein gp340 protects cottontop tamarins against EB virus-induced malignant lymphomas.
Morgan AJ, Mackett M, Finerty S, Arrand JR, Scullion FT, Epstein MA. Morgan AJ, et al. Among authors: finerty s. J Med Virol. 1988 Jun;25(2):189-95. doi: 10.1002/jmv.1890250209. J Med Virol. 1988. PMID: 2839612
Validation of a first-generation Epstein-Barr virus vaccine preparation suitable for human use.
Morgan AJ, Allison AC, Finerty S, Scullion FT, Byars NE, Epstein MA. Morgan AJ, et al. Among authors: finerty s. J Med Virol. 1989 Sep;29(1):74-8. doi: 10.1002/jmv.1890290114. J Med Virol. 1989. PMID: 2555448
42 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback